Koshinski Asset Management
BIB icon

Koshinski Asset Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Koshinski Asset Management’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,454
Closed -$276K – 709
2022
Q1 		$276K Sell
4,454
-134
-3% -$8.23K 0.02% 496
2021
Q4 		$372K Buy
4,588
+103
+2% +$8.82K 0.03% 469
2021
Q3 		$426K Buy
4,485
+38
+0.9% +$3.84K 0.04% 417
2021
Q2 		$438K Sell
4,447
-138
-3% -$12K 0.06% 355
2021
Q1 		$383K Sell
4,585
-111
-2% -$10.5K 0.04% 415
2020
Q4 		$405K Sell
4,696
-245
-5% -$19K 0.05% 368
2020
Q3 		$388 Sell
4,941
-47
-0.9% -$3.33K 0.05% 346
2020
Q2 		$362K Sell
4,988
-569
-10% -$36.3K 0.06% 346
2020
Q1 		$257K Hold
5,557
– – 0.05% 374
2019
Q4 		$340K Buy
+5,557
New +$296K 0.06% 386
2019
Q3 		– Sell
-5,077
Closed -$263K – 159
2019
Q2 		$263K Buy
5,077
+490
+11% +$24.4K 0.11% 221
2019
Q1 		$254 Buy
+4,587
New +$247K 0.07% 321
2018
Q4 		– Sell
-5,343
Closed -$372K – 415
2018
Q3 		$372K Buy
5,343
+1,420
+36% +$92.8K 0.05% 380
2018
Q2 		$224K Sell
3,923
-109
-3% -$5.94K 0.07% 342
2018
Q1 		$222K Sell
4,032
-1,100
-21% -$65.9K 0.07% 329
2017
Q4 		$288K Sell
5,132
-1,944
-27% -$110K 0.07% 345
2017
Q3 		$433K Buy
7,076
+213
+3% +$12.1K 0.14% 223
2017
Q2 		$366K Hold
6,863
– – 0.13% 233
2017
Q1 		$331K Buy
6,863
+47
+0.7% +$2.19K 0.13% 226
2016
Q4 		$272K Sell
6,816
-386
-5% -$16.5K 0.13% 228
2016
Q3 		$349K Buy
+7,202
New +$342K 0.17% 188
2016
Q1 		– Sell
-4,204
Closed -$301K – 224
2015
Q4 		$301K Buy
4,204
+188
+5% +$12.6K 0.21% 144
2015
Q3 		$363K Sell
4,016
-1,011
-20% -$86.2K 0.23% 138
2015
Q2 		$454K Buy
5,027
+25
+0.5% +$2.15K 0.29% 105
2015
Q1 		$396K Buy
5,002
+20
+0.4% +$1.48K 0.26% 116
2014
Q4 		$313K Buy
+4,982
New +$292K 0.18% 158

Other funds holding BIB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Koshinski Asset Management's BIB Position: Q2 2022 in Review

Koshinski Asset Management sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2022, closing a stake of 4,454 shares — an estimated $276K sold.

Koshinski Asset Management first reported a position in BIB in Q4 2014 and held it in 26 quarters. The position peaked at $454K in Q2 2015. 24 funds tracked by Wall St. Rank hold BIB as of Q2 2022.

  • Koshinski Asset Management reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 4,454 ProShares Ultra NASDAQ Biotechnology shares in Q2 2022, an estimated $276K.
  • Koshinski Asset Management first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2014 and held it in 26 quarters.
  • Koshinski Asset Management's ProShares Ultra NASDAQ Biotechnology position peaked at $454K in Q2 2015.
  • 24 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.